AI assistant
Sending…
Twist Bioscience Corp — Director's Dealing 2022
Feb 8, 2022
31873_dirs_2022-02-08_744e2695-e945-4585-a17e-b0a95482aea1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2022-02-04
Reporting Person: JOHANNESSEN JAN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-04 | Common Stock | S | 253 | $58.879 | Disposed | 1645 | Direct |
Footnotes
F1: Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously
granted to the Reporting Person.
More from Twist Bioscience Corp
Capital/Financing Update
2026
Jun 18
Earnings Release
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25